2020
DOI: 10.1021/acs.biochem.0c00005
|View full text |Cite
|
Sign up to set email alerts
|

IpdE1-IpdE2 Is a Heterotetrameric Acyl Coenzyme A Dehydrogenase That Is Widely Distributed in Steroid-Degrading Bacteria

Abstract: Steroid-degrading bacteria, including Mycobacterium tuberculosis (Mtb), utilize an architecturally distinct subfamily of acyl coenzyme A dehydrogenases (ACADs) for steroid catabolism. These ACADs are α2β2 heterotetramers that are usually encoded by adjacent fadE-like genes. In mycobacteria, ipdE1 and ipdE2 (formerly fadE30 and fadE33) occur in divergently transcribed operons associated with the catabolism of 3aα-H-4α­(3′-propanoate)-7aβ-methylhexahydro-1,5-indanedione (HIP), a steroid metabolite. In Mycobacter… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
10
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 12 publications
(10 citation statements)
references
References 46 publications
0
10
0
Order By: Relevance
“…In bile acid degradation, this reaction sequence can depend on the organism and on the hydroxylation pattern of the bile acid substrate, which is discussed in more detail below. In general, the side chain of HIP-CoA is dehydrogenated by heterotetrameric ACADs similar to the ones involved in steroid side-chain degradation [ 126 ]. In P. stutzeri Chol1 and C. testosteroni TA441, these ACADs are encoded by the genes scd3A / scd3B and scdC1/scdC2 , respectively [ 84 , 127 ].…”
Section: Bacterial Bile Acid Degradationmentioning
confidence: 99%
“…In bile acid degradation, this reaction sequence can depend on the organism and on the hydroxylation pattern of the bile acid substrate, which is discussed in more detail below. In general, the side chain of HIP-CoA is dehydrogenated by heterotetrameric ACADs similar to the ones involved in steroid side-chain degradation [ 126 ]. In P. stutzeri Chol1 and C. testosteroni TA441, these ACADs are encoded by the genes scd3A / scd3B and scdC1/scdC2 , respectively [ 84 , 127 ].…”
Section: Bacterial Bile Acid Degradationmentioning
confidence: 99%
“…+++ indicates only specific activity has been determined for this enzyme (41 μM min −1 mg −1 ). 26 different conditions, with unique packing interactions, and with the flavin in different apparent redox states (the ring in the Gly363Ala structure is bent at an angle of ∼23°, implying the reduced, FADH 2 form; experiments on the close homologue FadE26-FadE27 have established that X-ray radiation can reduce the cofactor in these enzymes during data collection 7 ). However, shifts of this magnitude do not typically occur in ACAD enzymes, and our interpretation is that these differences arise primarily as a consequence of the Gly363Ala variation that preferentially stabilizes a naturally occurring structural state of the enzyme, thereby enabling new crystallization conditions that stabilize a distinct crystal packing arrangement.…”
Section: ■ Resultsmentioning
confidence: 99%
“…In FadE34 and CasC, the two-domain ACADs that are specific to five-carbon side chain steroid substrates in the cholesterol and bile acid degradation pathways of M. tuberculosis and R. jostii RHA1, respectively, this residue is replaced by alanine. Finally, in M. tuberculosis FadE30 (also known as IpdE1), a recently characterized subunit of a heteromeric ACAD that is specific for the bicyclic, post-ring-opening C-ring side chain, this residue is replaced with tyrosine. This residue is also seen in SCAD and MCAD, while the equivalent residue Phe is found in human very long chain ACAD .…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Throughout the cholesterol catabolic pathway, we have identified protein architectures and assemblies that are unique to actinomycetes and Mtb. 26,30,[39][40][41][42] Importantly, chsB1 is required for the in vivo survival of Mtb in mice, 35 and the structures of ChsB1 elucidated in this work provide insight into binding site cavities that differ from its homologues and will allow discrimination between host and pathogen enzymes by inhibitors in the future. The enzymatic evolutionary adaptations that have emerged in Mtb for the breakdown of cholesterol and the in vivo essentiality of various genes in the pathway highlight the value of this pathway's enzymes for further exploitation in drug discovery.…”
Section: -Hoco-coamentioning
confidence: 88%